Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Rheum Dis ; 68(6): 789-96, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19066176

RESUMO

OBJECTIVE: The phase III GO-FORWARD study examined the efficacy and safety of golimumab in patients with active rheumatoid arthritis (RA) despite methotrexate therapy. METHODS: Patients were randomly assigned in a 3 : 3 : 2 : 2 ratio to receive placebo injections plus methotrexate capsules (group 1, n = 133), golimumab 100 mg injections plus placebo capsules (group 2, n = 133), golimumab 50 mg injections plus methotrexate capsules (group 3, n = 89), or golimumab 100 mg injections plus methotrexate capsules (group 4, n = 89). Injections were administered subcutaneously every 4 weeks. The co-primary endpoints were the proportion of patients with 20% or greater improvement in the American College of Rheumatology criteria (ACR20) at week 14 and the change from baseline in the health assessment questionnaire-disability index (HAQ-DI) score at week 24. RESULTS: The proportion of patients who achieved an ACR20 response at week 14 was 33.1% in the placebo plus methotrexate group, 44.4% (p = 0.059) in the golimumab 100 mg plus placebo group, 55.1% (p = 0.001) in the golimumab 50 mg plus methotrexate group and 56.2% (p<0.001) in the golimumab 100 mg plus methotrexate group. At week 24, median improvements from baseline in HAQ-DI scores were 0.13, 0.13 (p = 0.240), 0.38 (p<0.001) and 0.50 (p<0.001), respectively. During the placebo-controlled portion of the study (to week 16), serious adverse events occurred in 2.3%, 3.8%, 5.6% and 9.0% of patients and serious infections occurred in 0.8%, 0.8%, 2.2% and 5.6%, respectively. CONCLUSION: The addition of golimumab to methotrexate in patients with active RA despite methotrexate therapy significantly reduced the signs and symptoms of RA and improved physical function.


Assuntos
Anticorpos Monoclonais/administração & dosagem , Artrite Reumatoide/tratamento farmacológico , Imunossupressores/administração & dosagem , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Doença Aguda , Adulto , Análise de Variância , Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais/uso terapêutico , Artrite Reumatoide/imunologia , Artrite Reumatoide/microbiologia , Infecções Bacterianas/complicações , Distribuição de Qui-Quadrado , Método Duplo-Cego , Esquema de Medicação , Quimioterapia Combinada , Feminino , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Injeções Subcutâneas , Masculino , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Fatores de Tempo , Resultado do Tratamento
2.
J Biomech ; 16(9): 753-66, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6643546

RESUMO

Data are presented to compare fluid flow parameters for steady flow with those for time-varying flow in a simplified two branch model which simulates the region of the abdominal aorta near the celiac and superior mesenteric branches of the dog. Measurements in the model included laser doppler anemometry velocity profiles during steady flow, sinusoidal flow with a superimposed mean flow (referred to as simple oscillatory flow) and arterial pulsatile flow. Shear rate measurements were made by an electrochemical technique during steady flow. Flow visualization studies were done during steady and pulsatile flow. Fluid flow effects in the simplified model during steady flow showed many similarities to the results from previous steady flow studies in a canine aortic cast. Shear rates in the region of the proximal (first, or celiac) branch were independent of flow rates in the distal (second, or mesenteric) branch, but the shear pattern within the proximal branch changed significantly as flow in the proximal branch increased. Shear rates on the proximal flow divider (leading edge into the distal branch) depended primarily on the flow rate to the proximal branch, but not on flow to the distal branch. At certain daughter branch flow ratios (approximately 2:1, proximal to distal), flow separation was promoted at the outer wall of the second branch, but flow separation did not occur in the first branch. In contrast to the canine aortic case results, flow separation was never detected on the distal (mesenteric) flow divider of the simplified model. This observation reflects the subtle effects of geometry on flow since the mesenteric flow divider in the canine cast protrudes into the main flow whereas the distal flow divider in the simplified model does not. There were distinct differences in the flow phenomena between steady, simple oscillatory and arterial pulsatile flow. Peak shear rates during pulsatile flow were as much as 10--100 times greater than steady flow shear rates at comparable mean flow rates. Particularly noteworthy for the pulsatile flow with a Womersley parameter of sixteen were very blunt velocity profiles throughout systole, and the absence of flow separation or reversal in those regions of the model that exhibited flow separation during steady flow. The shape of the waveform influences the nature of the flow during time-varying flows. Future studies of fluid dynamics in model systems must consider the pulsatile nature of the flow if a true interpretation of arterial flow phenomena is to be made.


Assuntos
Aorta Abdominal/fisiologia , Artérias/fisiologia , Velocidade do Fluxo Sanguíneo , Modelos Anatômicos , Reologia , Artérias/anatomia & histologia , Modelos Cardiovasculares , Pulso Arterial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...